Drug to halt development of Alzheimer’s a step closer

A drug treatment which can halt Alzheimer’s disease may be on the horizon after promising results from an early stage clinical trial.

Experts are taking care not to build up false hopes about the antibody drug, aducanumab, which clears away sticky protein fragments in the brain linked to Alzheimer’s.

However, David Reynolds, chief scientific officer at Alzheimer’s Research UK, said: “These results provide tantalising evidence that a new class of drug to treat the disease may be on the horizon.